ArticleMicrobial cell factories2026
Efficient production of glycine from glucose via a two-stage biosynthetic strategy.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toward engineered microbial chassis for growth-production balancing.Synthetic and systems biotechnology · 2027Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHigh-quality glycine is widely used in the cosmetics and pharmaceutical industries. Conventional chemical synthesis of glycine is disfavored because it relies on toxic reagents and complex downstream purification.
resultsHerein, we established an efficient two-step biosynthetic process for producing glycine from glucose. First, an L-threonine−overproducing strain was used to synthesis L-threonine via 50 L fed-batch fermentation, achieving a titer of 119.3 g/L. Then, a highly active L-threonine aldolase (PpLTA) was screened to convert L-threonine into glycine. To overcome thermodynamic and acetaldehyde inhibition constraints, an acetaldehyde elimination system was constructed via introducing ScADH1 and ScCR, which increased the molar conversion yield of glycine increased by 3.9-fold. Whole-cell catalysis gave a significantly higher conversion yield than crude enzyme preparations. A whole-cell co-expressing PpLTA, ScADH1, and ScCR was subsequently constructed. Finally, at 50 L scale, direct conversion of L-threonine fermentation broth afforded a glycine titer of 65.4 g/L within 24 h, with a molar conversion yield of 87.2%, In addition, 99.8% pure glycine was obtained with a yield of 76.6% via separation.
conclusionsAn efficient two-step process for converting glucose to glycine was developed and successfully validated. Evaluation at the 50 L scale demonstrated record-high glycine production performance. This work provides a promising technological route for the industrial manufacture of high-quality glycine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.